// App-Quantinova.ai

LB937 : Presentation and management of immune checkpoint inhibitors-induced psoriasis: A single-center Experience

Researchers

Presenter

  • A. Jfri

Principal Investigators

  • B. Leung

  • N. LeBoeuf

Medical Centers

  • Department Of Ophthalmology, Harvard Medical School , Boston, Massachusetts, United States

  • Cutaneous Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Dermatology

  • Oncology (ONC)

  • Musculoskeletal

Disease

  • Psoriatic arthritis

  • Psoriasis

  • Inflammatory Arthritis

  • Melanoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Atezolizumab

  • Apremilast

  • Acitretine

  • Nivolumab

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved